249 related articles for article (PubMed ID: 31300371)
1. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.
Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C
Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371
[TBL] [Abstract][Full Text] [Related]
2. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
3. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
He XK; Su TT; Si JM; Sun LM
Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
[TBL] [Abstract][Full Text] [Related]
5. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
[TBL] [Abstract][Full Text] [Related]
6. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
7. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
Shuai Y; Li C; Zhou X
Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
[TBL] [Abstract][Full Text] [Related]
8. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
Wang Q; Shi M
Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
[TBL] [Abstract][Full Text] [Related]
9. Metformin may improve the prognosis of patients with pancreatic cancer.
Zhang JW; Sun Q
Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
[TBL] [Abstract][Full Text] [Related]
10. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
Wang Y; Xiao J; Zhao Y; Du S; Du J
Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis.
Luo S; Li JY; Zhao LN; Yu T; Zhong W; Xia ZS; Shan TD; Ouyang H; Yang HS; Chen QK
Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):110-23. PubMed ID: 26162991
[TBL] [Abstract][Full Text] [Related]
12. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis.
Yang WT; Yang HJ; Zhou JG; Liu JL
Int J Colorectal Dis; 2020 Nov; 35(11):2117-2131. PubMed ID: 32720184
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
Zhang ZJ; Li S
Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896
[TBL] [Abstract][Full Text] [Related]
14. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
[TBL] [Abstract][Full Text] [Related]
15. Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis.
Petrelli F; Ghidini M; Rausa E; Ghidini A; Cabiddu M; Borgonovo K; Ghilardi M; Parati MC; Pietrantonio F; Sganzerla P; Bossi AC
Can J Diabetes; 2021 Mar; 45(2):186-197.e2. PubMed ID: 33039329
[TBL] [Abstract][Full Text] [Related]
16. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
[TBL] [Abstract][Full Text] [Related]
18. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.
Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N
Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114
[TBL] [Abstract][Full Text] [Related]
19. Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
Mekuria AN; Ayele Y; Tola A; Mishore KM
J Diabetes Res; 2019; 2019():7676909. PubMed ID: 31828167
[TBL] [Abstract][Full Text] [Related]
20. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]